NASDAQ: RARE       Ultragenyx Pharmaceu
Last Price Today's Change   Day's Range   Trading Volume
50.85   +1.24 (2.50%)  49.90 - 51.47  501,000


Avg Volume (4 weeks):684,205
4 Weeks Range:46.17 - 52.15
4 Weeks Price Volatility (%):
52 Weeks Range:34.00 - 66.74
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Ultragenyx Pharmaceuticals is a biotechnology company, focused on the identification, development, and commercialization of products that treat genetic diseases. The business focuses on treating ultra-rare and debilitating diseases. The company develops biologic candidates. One example of Ultragenyx’s products currently in clinical trials is KRN23, a human-monoclonal antibody that binds and reduces the biological activity of fibroblast growth factor 23 to enhance low phosphate levels in patients with either X-linked hypophosphatemia or tumor-induced osteomalacia. Additionally, the company produces products for fatty acid oxidation disorders and treatments for GNE myopathy. The company generates the vast majority of its revenue in the United States.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

6687  2946  917  902 

Top 10 Active Counters
 TSLA 213.97+6.45 
 SQQQ 21.74-0.48 
 TQQQ 36.82+0.81 
 T 15.21-0.60 
 UTRS 0.293+0.093 
 MMV 2.04+1.09 
 SPY 427.92+6.10 
 YJ 0.32+0.108 
 PLTR 14.52-0.02 
 BAC 28.71+0.93